Parylene-C Coating Prevents Reproductive Toxicity in 3D-Printed Resins
Researchers found that four ISO 10993 biocompatible resins used in 3D printing cause reproductive toxicity in mammalian oocytes and embryos, despite passing standard biocompatibility tests. A 5-micron Parylene-C coating completely prevented these toxic effects across all tested resins, even restoring fertility in the most cytotoxic material. This finding could enable safer use of 3D-printed materials in microphysiological systems and other applications requiring sensitive cell cultures.
Scientists developed a Multi-Endpoint Oocyte Safety Assay (MEIOSA) to test the biocompatibility of four BioMed resins commonly used in 3D printing for creating microphysiological systems. When oocytes were cultured in inserts printed with these resins—Clear, Durable, Elastic 50A, and Flex 80A—they exhibited impaired meiotic progression or complete degeneration, despite the resins meeting ISO 10993 biocompatibility standards. The researchers discovered that coating the resin inserts with a 5-micron Parylene-C barrier completely rescued both the degeneration and meiotic maturation defects. Notably, oocytes matured in Parylene-C-coated Flex 80A (the most toxic resin) became fertilization-competent and produced embryos capable of normal preimplantation development. The study demonstrates that standard viability-based biocompatibility tests may not detect cytotoxic effects on all cell types, and establishes MEIOSA as a sensitive screening tool for biomaterial evaluation.
Limitations & open questions
The study does not discuss the cost, scalability, or manufacturing feasibility of applying Parylene-C coatings to 3D-printed materials at production scale. Additionally, the mechanisms underlying the resin cytotoxicity and how Parylene-C prevents it are not detailed. The generalizability of findings to other sensitive cell types beyond reproductive cells is mentioned conceptually but not experimentally demonstrated.
What different sources said
- bioRxivCenter
Biocompatible designated Resin-3D-printed polymers exhibit reproductive toxicity prevented by Parylene-C
Related
Study reveals IDH1 enzyme's role in cardiac metabolic adaptation during cancer-related stress
Researchers discovered that isocitrate dehydrogenase 1 (IDH1) helps the heart adapt to metabolic stress caused by cancer-related mutations through a previously unknown reductive metabolic pathway. The study used stable isotope tracing and genetic knockout models in rat and mouse heart tissue to show that when mitochondrial metabolism is impaired, IDH1 redirects carbon flux toward glutamine-derived citrate formation. This finding expands understanding of how cardiac metabolism responds to oncometabolic stress and may have implications for managing cardiovascular complications in cancer patients.
AI Framework Reveals How β-Arrestin 1 Protein Changes Shape During Activation
Researchers used a transformer-based artificial intelligence model to analyze how the β-arrestin 1 protein's tail region reorganizes when activated by cell surface receptors. The study examined molecular dynamics simulations comparing the protein in resting and active states, uncovering previously unknown conformational changes. This work could improve understanding of how cells regulate signaling pathways involved in numerous physiological and disease processes.
Study Links Pancreatic Cancer Tissue Stiffness to Tumor Progression and Patient Survival
Researchers combined imaging scans and laboratory tissue analysis to show that pancreatic cancer tumors with greater stiffness—driven by dense collagen buildup—correlate with worse patient survival outcomes. The study of nine patients found that magnetic resonance elastography, a non-invasive imaging technique, can detect mechanical properties that reflect underlying tumor biology. These findings suggest that measuring tissue stiffness through imaging could help doctors better characterize pancreatic cancer and guide treatment decisions.